Travel vaccination for rabies (Q37194785)

18 August 2017

1 reference

title

Travel vaccination for rabies (English)

1 reference

18 August 2017

0 references

Charles Edward Rupprecht

series ordinal

2

object named as

Charles E Rupprecht

1 reference

18 August 2017

1

Jesse D Blanton

1 reference

18 August 2017

publication date

1 July 2008

1 reference

Expert Review of Vaccines

18 August 2017

published in

1 reference

18 August 2017

volume

7

1 reference

18 August 2017

issue

5

1 reference

18 August 2017

page(s)

613-620

1 reference

Pathophysiology of human paralytic rabies

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

Transmission of rabies virus from an organ donor to four transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

Human-to-Human Transmission of Rabies Virus by Corneal Transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

Survey for bat lyssaviruses, Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

21 January 2018

Lagos bat virus in Kenya

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

Efficacy of rabies biologics against new lyssaviruses from Eurasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

Current and future trends in the prevention, treatment and control of rabies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

Rabies surveillance in the United States during 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

Revisiting rabies in Japan: is there cause for alarm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

A comparative study on the immunogenicity, safety and tolerance of purified duck embryo vaccine (PDEV) manufactured in India (Vaxirab) and Switzerland (Lyssavac-N): a randomized simulated post-exposure study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

Economic issues in postexposure rabies treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

Epidemiology of human rabies in the United States, 1980 to 1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

Pre-exposure rabies prophylaxis for the international traveller: a decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

Rabies postexposure prophylaxis, New York, 1995-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

Survival after treatment of rabies with induction of coma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

World Rabies Day: focusing attention on a neglected disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

Control of rabies: epidemiology of rabies in Asia and development of new-generation vaccines for rabies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

Current status of human rabies transmitted by dogs in Latin America

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

Climate change and the effects of temperature extremes on Australian flying-foxes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.613

21 January 2018

Identifiers

DOI

10.1586/14760584.7.5.613

1 reference

release_p3veuadrqvgrbjb65ny3aqwy3y

18 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p3veuadrqvgrbjb65ny3aqwy3y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference